Key players in the plasma fractionation market include CSL (Australia), Takeda Pharmaceutical company limited (Japan), Grifols, S.A. (Spain), Octapharma AG (Switzerland), Kedrion S.P.A (Italy), LFB (France), ADMA Biologics (US) The plasma fractionation industry is poised for remarkable growth in the near future, driven by several factors including advancements in biotechnology, increasing demand for plasma-derived therapies, […]
